| Literature DB >> 29415715 |
Soo-Youn Moon1, Ki-Ho Park1, Mi Suk Lee1, Jun Seong Son2.
Abstract
BACKGROUND: Traditional Oriental medicine is used in many Asian countries and involves herbal medicines, acupuncture, moxibustion, and cupping. We investigated the incidence and causes of hospital-acquired fever (HAF) and the characteristics of febrile inpatients in Oriental medical hospitals (OMHs).Entities:
Keywords: Etiology; Fever; Hospital-acquired; Traditional oriental medicine
Mesh:
Substances:
Year: 2018 PMID: 29415715 PMCID: PMC5804080 DOI: 10.1186/s12913-018-2896-1
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Etiology of Hospital-acquired Fever in OMHs
| Category | No. (%) |
|---|---|
| Infection | 331 (59.1) |
| Respiratory tract | 166 (51.2) |
| Urinary tract | 99 (30.6) |
| Intra-abdominal | 39 (12.1) |
| Skin and soft tissue | 18 (3.2) |
| Primary bacteremia/fungemia | 10 (3.1) |
| Central nervous system | 2 (0.6) |
| Bone & joint | 2 (0.6) |
| Other | 2 (0.6) |
| Non-infection | 179 (32.0) |
| Drug fever | 101 (56.4) |
| Post-procedure | 24 (13.4) |
| Cancer fever | 23 (12.8) |
| Transfusion related | 7 (3.9) |
| Dehydration related | 3 (1.7) |
| ICH related central fevera | 2 (1.1) |
| Other | 19 (10.6) |
| Unknown | 50 (8.9) |
aICH intracranial hemorrhage
Incidence of drug fever and procedure-related fever among patients receiving herbal medicine and/or oriental procedures among patients admitted to OMHs (n = 11,207)
| Risk factor | No. of patients with risk factors | No. of patients with risk factors who developed fever | Percentage |
|---|---|---|---|
| Herbal medicine | 10,880 | 95 | 0.87 |
| Invasive oriental medical procedures | 8125 | 16 | 0.20 |
| Acupuncture | 8040 | 8 | 0.10 |
| Moxibustion | 6585 | 7 | 0.11 |
| Cupping | 4267 | 1 | 0.02 |
Characteristics of Patients with HAF in OMH by Etiology
| Total | Infection | Non-infection |
| |
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 61.4 ± 15.2 | 63.7 ± 15.3 | 58.0 ± 14.7 | < 0.001 |
| Male sex | 278 (49.6) | 169 (51.1) | 81 (45.3) | 0.228 |
| Underlying diseases | ||||
| Diabets mellitus | 141 (25.2) | 90 (27.2) | 40 (22.3) | 0.243 |
| Hypertension | 234 (41.8) | 161 (48.6) | 60 (33.5) | 0.001 |
| Cerebrovascular accident | 251 (44.8) | 179 (54.1) | 63 (35.2) | < 0.001 |
| Solid cancer | 246 (43.9) | 109 (32.9) | 100 (55.9) | < 0.001 |
| Metastatic cancer | 205 (36.6) | 88 (26.6) | 85 (47.5) | < 0.001 |
| Healthcare- associatied conditions | ||||
| Receipt of anticancer chemotherapy | 113 (20.2) | 40 (12.1) | 56 (31.3) | < 0.001 |
| Central venous catheter | 68 (12.1) | 43 (13.0) | 21 (11.7) | 0.682 |
| Urinary catheter | 111 (19.8) | 79 (23.9) | 27 (15.1) | 0.022 |
| Percutaneous drainage | 68 (12.1) | 47 (14.2) | 20 (11.2) | 0.410 |
| Previous operation | 76 (13.6) | 47 (14.2) | 21 (11.7) | 0.434 |
| Previous intervention | 24 (4.3) | 14 (4.2) | 9 (5.0) | 0.678 |
| Previous admission | 414 (74.0) | 250 (75.5) | 134 (74.9) | 0.867 |
| Previous antibiotics | 128 (22.9) | 98 (29.6) | 27 (15.1) | < 0.001 |
| Concurrent treatment | ||||
| Herbal medicine | 506 (90.4) | 310 (93.7) | 161 (89.9) | 0.132 |
| Invasive Oriental medical procedure | 532 (95.0) | 314 (94.9) | 171 (95.5) | 0.739 |
| Acupuncture | 502 (89.6) | 302 (91.2) | 161 (89.9) | 0.630 |
| Cupping | 97 (17.3) | 56 (17.0) | 35 (19.6) | 0.468 |
| Moxibustion | 417 (74.5) | 242 (73.3) | 138 (77.1) | 0.352 |
| SIRSa (severe or shock) | 47 (8.4) | 28 (8.5) | 14 (7.8) | 0.788 |
| Laboratory findings at the onset of fever | ||||
| White Blood Cell(/mm3) | 9550 (100–32,500) | 10,400 (800–32,500) | 7000 (100–24,000) | < 0.001 |
| Neutropenia (WBC < 1000/mm3) | 5 (0.9) | 3 (1.0) | 2 (1.3) | 0.662 |
| C-reactive protein | 5.3 (0.0–39.7) | 5.4 (0.0–39.7) | 4.2 (0.0–22.5) | 0.767 |
| Fever pattern | ||||
| Peak body temperature (°C) | 38.5 ± 0.6 | 38.6 ± 0.6 | 38.4 ± 0.6 | 0.151 |
| Duration of fever | 1.0 (0.0–18.0) | 1.0 (0.0–18.0) | 1.0 (0.0–17.0) | 0.263 |
| No defervescence | 43 (7.7) | 23 (6.9) | 12 (6.7) | 0.917 |
aSIRS systemic inflammatory response syndrome
Management and clinical outcome of febrile patients in OMH
| Total (n = 560) | Infection (n = 331) | Non-infection (n = 179) |
| |
|---|---|---|---|---|
| Medical consult | 297 (53.0) | 241 (72.8) | 47 (26.3) | < 0.001 |
| Antibiotics | 302 (53.9) | 244 (73.7) | 45 (25.1) | < 0.001 |
| Duration of antibiotics | 8.0 (0.0–40.0) | 9 (1–40) | 5.5 (1–21) | 0.002 |
| Antipyretics | 112 (20.0) | 72 (21.8) | 31 (17.3) | 0.339 |
| Surgical treatment | 7 (1.3) | 3 (0.9) | 4 (2.2) | 0.248 |
| 30-day mortality | 46/477 (9.6) | 21 (7.6) | 14 (8.9) | 0.616 |
Factors associated with infectious origin in febrile illness in OMHs
| Univariate analysis |
| Multivariate analysis |
| |
|---|---|---|---|---|
| OR (95% C.I.) | OR (95% C.I.) | |||
| Age > 65 | 2.250 (1.544–3.277) | < 0.001 | 1.666 (1.082–2.564) | 0.020 |
| Hypertension | 1.878 (1.287–2.741) | 0.001 | ||
| Cerebrovascular accident | 2.168 (1.490–3.156) | < 0.001 | ||
| Urinary catheter | 1.765 (1.091–2.855) | 0.021 | ||
| Previous antibiotic | 2.368 (1.475–3.798) | < 0.001 | 3.166 (1.852–5.413) | < 0.001 |
| WBC > 10,000 | 3.730 (2.415–5.760) | < 0.001 | 2.223 (1.486–3.324) | < 0.001 |
| Solid cancer | 0.330 (0.232–0.468) | < 0.001 | 0.263 (0.116–0.594) | 0.001 |
| Metastatic cancer | 0.347 (0.243–0.495) | < 0.001 | ||
| Recipient of anticancer chemotherapy | 0.294 (0.191–0.452) | < 0.001 | 0.507 (0.289–0.0887) | 0.017 |